HERBALIFE LTD.

HLFSEC EDGAR

Wholesale-Drugs, Proprietaries & Druggists' Sundries(E9)CIK: 1180262

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$5.1B	$5.2B	$5.8B	$5.5B	$4.9B
Cost of Goods and Services Sold	$1.2B	$1.2B	$1.2B	$1.2B	$958.0M
Gross Profit	$3.9B	$4.0B	$4.6B	$4.4B	$3.9B
Selling, General and Administrative Expense	—	$1.8B	$2.0B	$2.1B	$1.9B
Operating Income (Loss)	$356.4M	$545.2M	$734.1M	$640.6M	$568.1M
Interest Expense	$165.9M	$139.3M	$153.1M	$133.0M	$153.0M
Other Nonoperating Income (Expense)	$1.0M	$12.8M	-$24.6M	$0.00

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$2.7B	$2.8B	$2.7B	$2.8B	$3.1B
Assets, Current	$1.1B	$1.4B	$1.4B	$1.4B	$1.8B
Cash and Cash Equivalents, at Carrying Value	$415.3M	$575.2M	$508.0M	$601.5M	$1.0B
Inventory, Net	$475.4M	$505.2M	$580.7M	$575.7M	$501.4M
Liabilities	$3.5B	$3.9B	$4.0B	$4.2B	$3.9B
Liabilities, Current	$1.2B	$1.3B	$976.6M	$1.1B	$1.1B
Long-term Debt	$2.3B	$2.6B	$2.7B	$2.8B	$2.4B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$357.5M	$352.5M	$460.3M	$628.6M	$457.5M
Net Cash Provided by (Used in) Investing Activities	-$134.8M	-$156.2M	-$156.4M	-$123.2M	-$108.0M
Net Cash Provided by (Used in) Financing Activities	-$148.3M	-$264.7M	-$728.6M	-$320.9M	-$713.0M
Payments to Acquire Property, Plant, and Equipment	$135.0M	$156.4M	$151.4M	$112.0M	$106.1M
Payments of Ordinary Dividends, Common Stock	—	—	—	—	—
Payments for Repurchase of Common Stock	$11.0M	$146.7M	$1.0B	$923.5M	$16.7M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)